Nucleic Acid Labelling have many applications in fields of drug discovery and identification of new diseases

Nucleic Acid Labelling Market was worth $1631.2 million in 2018 and estimated to be growing at a CAGR of 8.65%, to reach $2469.77 million by 2023. Nucleic Acid Labelling have many applications in fields of drug discovery and identification of new diseases.Nucleic acids are large complex molecules which carry genetic information. Two major types of nucleic acids are DNA and RNA. DNA carries forward function of hereditary characteristics to next generation while RNA carries protein synthesis. Nucleic acids are labelled with tags which facilitate the detection and purification process. There are many methods involving chemicals and enzymes for labelling nucleic acids like corporation of fluorescent tags, radioactive phosphates, and modifications with biotin, which are primarily utilized in biotechnology applications.

Market Drivers and Restraints:

The growth of Nucleic Acid Labelling market is attributed to factors like increasing expenditure for health care, increasing funding for R&D in genomics and disease diagnosis, increasing demand for personalized healthcare. However, factors like expensive processing techniques and lack of skilled professionals are likely to obstruct the growth of market.

To know more, click on the link below:

Report segmented as

By Product Type:

  • Reagents & Kits,
  • Services

By Technique:

  • PCR,
  • Nick Translation,
  • Random Primer,
  • In-Vitro Transcription,
  • Reverse Transcription

By Application:

  • DNA Sequencing,
  • PCR,
  • FISH,
  • Microarrays,
  • Blotting,
  • In-Situ Hybridization

By End Users:

  • Diagnostic Centres,
  • Research Centres,
  • Hospitals

Geographical Analysis:

Based on Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa. North America is leading the market while Europe is at second place. Increasing personalized medicines, identifying the genetic modifications and therapeutic areas have enabled North America to dominate the market. Asia Pacific is expected to grow the fastest due to government initiatives to develop healthcare infrastructure and making the products cost efficient and increased R&D expenditure.

Important Market Players:

Some of the key players dominating this market include Thermo Fisher Scientific, New England Biolabs, PerkinElmer, F. Hoffmann La-Roche AG, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.

View a sample and decide @

The Scope of the report:

This report offers the current product and services market evaluation and the future estimation of the market. It helps us understand the market better through size anticipation and CAGR calculation to estimate the next market. It has a broader segmentation for better understanding of the enterprising of the market at a low level by segregating the market into smaller sectors.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast


Tel: +1-888-702-9626